Tenax Therapeutics, Inc. - Common Stock (NQ:TENX)

1.860 +0.020 (+1.09%)

Delayed Quote Updated: 9:32 AM EST, Nov 4, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Tenax Therapeutics, Inc. - Common Stock

< Previous 1 2 3 4 5 6 7 Next >

Pomerantz Law Firm Announces the Filing of a Class Action Against Tenax Therapeutics, Inc. and Certain Officers – TENX

November 03, 2026

From Pomerantz LLP

Via GlobeNewswire

Securities Fraud Class Action Lawsuit Pending Against Tenax Therapeutics, Inc.: The Law Offices of Howard G. Smith Highlights Lead Plaintiff Deadline

November 03, 2026

From The Law Offices of Howard G. Smith

Via Business Wire

Securities Fraud Class Action Filed Against Tenax Therapeutics, Inc.: Glancy Prongay Wolke & Rotter LLP Announces Lead Plaintiff Deadline

November 03, 2026

From Glancy Prongay Wolke & Rotter LLP

Via Business Wire

Tenax Therapeutics (NASDAQ:TENX) Q1 2026 Slightly Beats EPS, Gears Up for Pivotal Phase 3 Data in Q3 ↗

May 12, 2026

Via Chartmill

SueWallSt Reminds Tenax Therapeutics Investors of the Pending Class Action Lawsuit With a Lead Plaintiff Deadline of December 28, 2026 - TENX

November 03, 2026

A securities fraud class action puts the Tenax promise-reality gap on the record. Management pointed to a 29-meter Phase 2 walk result, while the lawsuit claims TNX-103 was less effective than...

From SueWallSt

Via GlobeNewswire

Securities Fraud Lawsuit Filed Against Tenax Therapeutics, Inc.: The Law Offices of Frank R. Cruz Outlines Lead Plaintiff Deadline

November 02, 2026

From The Law Offices of Frank R. Cruz

Via Business Wire

TENX Shareholder Alert: Investors With Losses May Seek to Lead the Class Action in Tenax Therapeutics Securities Lawsuit - Contact Levi & Korsinsky

November 02, 2026

Important Information Regarding Section 20(a) Individual Liability Claims: Tenax's chief executive and three successive chief financial officers face control person claims over allegedly misleading...

From Levi & Korsinsky, LLP

Via GlobeNewswire

Why Is Tenax Therapeutics (TENX) Stock Up 29% Today? ↗

August 06, 2024

Tenax Therapeutics stock is up on Tuesday after the company revealed an oversubscribed private placement for TENX shares.

Via InvestorPlace

ROSEN, A RANKED AND LEADING LAW FIRM, Encourages Tenax Therapeutics, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - TENX

November 01, 2026

From The Rosen Law Firm PA

Via GlobeNewswire

TENX Shareholder Alert: December 28, 2026 Lead Plaintiff Deadline in Tenax Therapeutics, Inc. Securities Class Action - Contact Levi & Korsinsky

October 30, 2026

From Levi & Korsinsky, LLP

Via ACCESS Newswire

Lost Money on Tenax Therapeutics, Inc. Stock? Glancy Prongay Wolke & Rotter LLP Investigates Possible Securities Fraud After 89.77% Share Price Drop

October 30, 2026

From Glancy Prongay Wolke & Rotter LLP

Via Business Wire

Did You Lose Money on Tenax Therapeutics, Inc. Stock? The Law Offices of Howard G. Smith Announces Securities Fraud Investigation After 89.77% Share Price Decline

October 30, 2026

From The Law Offices of Howard G. Smith

Via Business Wire

TENX INVESTOR DEADLINE: Tenax Therapeutics, Inc. Investors with Substantial Losses May Seek to Lead Class Action Lawsuit

October 29, 2026

From Robbins Geller Rudman & Dowd LLP

Via Business Wire

ROSEN, SKILLED INVESTOR COUNSEL, Encourages Tenax Therapeutics, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - TENX

October 29, 2026

From The Rosen Law Firm PA

Via GlobeNewswire

Lost Money on Tenax Therapeutics, Inc. Shares? The Law Offices of Frank R. Cruz Investigates Potential Securities Fraud After 89.77% Stock Decline

October 29, 2026

From The Law Offices of Frank R. Cruz

Via Business Wire

Rosen Law Firm Urges Tenax Therapeutics, Inc. (NASDAQ: TENX) Stockholders with Large Losses to Contact the Firm for Information About Their Rights

October 28, 2026

From Rosen Law Firm

Via Business Wire

Pomerantz Law Firm Announces the Filing of a Class Action Against Tenax Therapeutics, Inc. and Certain Officers – TENX

October 27, 2026

From Pomerantz LLP

Via GlobeNewswire

Investor Alert: Robbins LLP Informs Investors of the Tenax Therapeutics, Inc. Class Action Lawsuit

October 27, 2026

From Robbins LLP

Via Business Wire

Let's uncover which stocks are experiencing notable gaps during today's session. ↗

August 25, 2026

Via Chartmill

TENX Investors Have Opportunity to Join Tenax Therapeutics, Inc. Fraud Investigation with SBS Law

August 16, 2026

From Schall, Brown & Schwartz LLP

Via Business Wire

TENX Investor Alert: Levi & Korsinsky Notifies Investors of Investigation Into Tenax Therapeutics (TENX)

August 14, 2026

From Levi & Korsinsky, LLP

Via Business Wire

Tenax LEVEL Trial Misses Primary Goal, but Subgroup Data Bolsters Levosimendan Case ↗

August 11, 2026

Tenax Therapeutics (NASDAQ:TENX) reported that its Phase III LEVEL trial of oral levosimendan in patients with pulmonary hypertension associated with heart failure with preserved ejection fraction, or...

Via MarketBeat

Get insights into the top gainers and losers of Thursday's pre-market session. ↗

July 02, 2026

Via Chartmill

Let's have a look at the top gainers and losers in the middle of the day of today's session. ↗

March 10, 2026

Via Chartmill

Tenax Posts Wider Loss in Fiscal Q2 ↗

August 13, 2025

Via The Motley Fool

Topics Intellectual Property

This Sempra Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Thursday ↗

October 24, 2024

Via Benzinga

TENX Stock Earnings: Tenax Therapeutics Beats EPS for Q2 2024 ↗

August 13, 2024

TENX stock results show that Tenax Therapeutics beat analyst estimates for earnings per share the second quarter of 2024.

Via InvestorPlace

12 Health Care Stocks Moving In Thursday's Intraday Session ↗

July 04, 2024

Via Benzinga

TENX Stock Earnings: Tenax Therapeutics Misses EPS for Q1 2024 ↗

May 14, 2024

TENX stock results show that Tenax Therapeutics missed analyst estimates for earnings per share the first quarter of 2024.

Via InvestorPlace

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday ↗

April 18, 2024

Pre-market stock movers are worth checking out as we dive into all of the biggest news sending shares higher and lower on Thursday morning!

Via InvestorPlace

< Previous 1 2 3 4 5 6 7 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io. Quotes delayed at least 20 minutes. Market data may be delayed. Research information, not personalized advice.